Cyclin D1 expression may be regulated in prostate cancer as a consequence of AKT-mediated activation leading to overexpression of several key proteins including Cyclin D1 [55], [56], a hypothesis, which is also supported by our data. The gene discussed is CCND1; the disease is prostate carcinoma.